Navigation Links
Parallax Achieves Major Milestone With License to Serve Medicare Part B Patients Through its RoxSan Subsidiary, Across 42 States.
Date:12/5/2016

SANTA MONICA, Calif., Dec. 5, 2016 /PRNewswire/ -- Parallax Health Sciences, Inc. ("Parallax" or the "Company") (OTC PINK: PRLX), is pleased to announce that its pharmaceutical business, RoxSan Pharmacy, Inc. has received a license to serve Medicare B clients, allowing coverage in all of the 42 states it is currently licensed to do business in.

Michael Rashti Pharm. D, Pharmacist in Charge at RoxSan Pharmacy, says, "This is a very exciting for our business. Medicare B spending last year came to roughly $170 Billion, accounting for about 14% of all Medicare Spending. This dramatically expands our potential client base while allowing RoxSan to deliver world-class services and products to a much wider audience geographically. Securing this Medicare Part B license also moves Parallax a big step closer to our goal of becoming health insurance agnostic. We want to serve anyone with a need, regardless of Insurance provider."

Having Medicare Part B coverage also allows for other Parallax products to be offered through RoxSan Pharmacy. The perfect synergies of the Parallax divisions will provide better patient care, while expanding the patient population the company can serve.

ABOUT MEDICARE PART B

Medicare Part B ("Part B") covers services (like lab tests, surgeries, and doctor visits) and supplies (like wheelchairs and walkers) considered medically necessary to treat a disease or condition.

"Part B" covers things like:

  • Clinical research 
  • Ambulance services
  • Durable medical equipment (DME)
  • Mental health
  • Inpatient
  • Outpatient
  • Partial hospitalization
  • Getting a second opinion before surgery
  • Limited outpatient prescription drugs

ABOUT ROXSAN PHARMACY, INC.

RoxSan Pharmacy, Inc. is a wholly owned subsidiary of Parallax Health Sciences, Inc. a publicly traded healthcare company under the symbol "PRLX" on the OTC Market.  RoxSan Pharmacy, Inc. is a 60 year old Beverly Hills, CA based Pharmacy specializing in Compound prescriptions and infertility treatments. RoxSan Pharmacy is licensed in 42 States in the US.

www.roxsan.com

ABOUT PARALLAX HEALTH SCIENCES, INC.

Parallax Health Sciences, Inc. ("Parallax Health") is an innovative biomedical health-care company headquartered in Santa Monica, California, which operates under three divisions: Pharmaceuticals, Diagnostics, and Remote Patient Monitoring. Each of these three divisions target a separate vertical market that are synergistic, compliment and strengthen each other and our value proposition as a whole.

Parallax Health's primary goal since inception has been to develop, license and or acquire, quality products and deliver those to our customers, patients, payers, health care facilities and providers, in the US and around the world.  It is the mission behind the founding of Parallax that we strive at all times to identify products, services and technologies that deliver solutions and fill the void in the current market for high quality, high efficacy products and services delivered at reasonable and rational prices.

www.parallaxhealthsciences.com

QOLPOM, Inc. ("QOLPOM") is our Tucson, AZ based systems integration company, providing Telehealth and remote patient monitoring ("RPM") solutions to the major stakeholders in the healthcare industry through its novel platform. QOLPOM's platform was designed to provide the flexibility to work with clients existing IT infrastructure and systems, while delivering scalability through its cloud based software.

www.qolpom.com

Parallax Diagnostics, Inc. is our Santa Monica, CA based point of care diagnostic testing company focused on the exploitation of a proprietary diagnostic device for the areas of Infectious Diseases, Cardiac Markers, Drugs of Abuse tests and various other medical conditions. The Company has patented and patent pending diagnostic testing devices, and tests that include a previously FDA Cleared 510K desktop analyzer for both qualitative and quantitative assays and twenty-four FDA 510K-previously cleared diagnostic tests. The Company plans to develop a novel CD4-8 Rapid Immune Status test targeting the HIV/AIDS/TB treatment and monitoring market.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/parallax-achieves-major-milestone-with-license-to-serve-medicare-part-b-patients-through-its-roxsan-subsidiary-across-42-states-300373012.html


'/>"/>
SOURCE Parallax Health Sciences, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. CVS Health Achieves 100 Percent on 2017 Corporate Equality Index for Third Consecutive Year
2. Cogentix Medical Reports 104% Revenue Growth for the Quarter Ended December 31; Achieves Cash Operating Profit Milestone
3. WellCares Exactus Pharmacy Solutions Achieves URAC Specialty Pharmacy Accreditation
4. Bluestar Silicones Achieves ISO 8 And ISO 7 Clean Room Certification; Promotes Long-Term Implant Offering At MD&M West
5. NEUMANN Diagnostics Automated Cervical Cancer Test Achieves Exceptional Accuracy
6. Telotristat Etiprate Achieves Positive Top-Line Results In Second Phase 3 Clinical Trial
7. CVS Health Achieves Perfect Score on 14th Annual Scorecard on LGBT Workplace Equality for Second Consecutive Year
8. VirtualScopics, Inc. Reports 2015 Third Quarter Revenues Increase 18% From Prior Year Period And Company Achieves Positive Adjusted EBITDA
9. Omnicell Achieves Record Revenue in the Third Quarter 2015
10. ORYZON Achieves Milestone in the Clinical Development of ORY-1001
11. Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)... , May 4, 2017  A new tight-tolerance ... and other highly-engineered materials, is being launched by ... has been developed in recent years to service ... and surgical applications. More expensive materials such as ... microextrusion tubing due to their ability to consistently ...
(Date:5/3/2017)...  Getinge, a leading global provider of products ... cost efficiency within healthcare and life sciences, today ... demonstrating that intra-aortic balloon counterpulsation (IABC) appears effective ... The single-center, retrospective, observational study showed that use ... 50cc intra-aortic balloon (IAB) in contemporary practice ...
(Date:5/2/2017)... Iowa , May 2, 2017  CIVCO ... patient-centric radiotherapy solutions, announced today that Nat ... been with CIVCO since 2012 and has served ... management, senior vice president and general manager, and ... "I am extremely proud of what ...
Breaking Medicine Technology:
(Date:5/23/2017)... ... , ... Orbita’s Nathan Treloar will discuss the role of voice-powered healthcare applications ... Connected Health and IoT: Technology Innovators and Disruption , the workshop is part of ... research and consulting firm specializing in emerging consumer technology products and services. , ...
(Date:5/23/2017)... ... , ... Patients in need of a pulpotomy in Mt. Horeb, ... with or without a referral. Dr. Cotey is a respected dental provider of general ... healthy alternative to a tooth extraction. , When a child has a severely infected ...
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... Today, Our ... Washington, MO with a public ribbon cutting ceremony. Since opening over a ... an alternative to the emergency room. The new Our Urgent Care walk-in clinic ...
(Date:5/22/2017)... ... ... Faithfully following pop culture, people today are forever in pursuit of physical ... programs. It carries on to skin nourished, pampered and nurtured to be soft and ... CDA has found that just like a perfectly cut and polished diamond, that ...
(Date:5/21/2017)... (PRWEB) , ... May 19, 2017 , ... ... pleased to announce the appointment of James (Jim) Vertino as Chief Information Officer ... a proven, transformational leader who drives innovation and business performance. He defines strategic ...
Breaking Medicine News(10 mins):